More than 8 months since the pandemic began, we now have a clearer picture of how COVID-19 affects people with cancer.
We’re calling on UK governments to stand by their commitments to improving cancer survival and make sure everyone can receive the care they deserve.
This autumn the chancellor Rishi Sunak will set out the Government’s spending priorities. Here’s why it’s time to invest in cancer services and research.
We’ve estimated it will cost HEE between £142 million and £260 million more than it already invests to grow the key cancer professions by 45%.
Six months since lockdown, we’ve got a much clearer picture how cancer services were affected, and how well they’re recovering.
We spoke to Professor Lou Chesler and Dr Lynley Marshall about the innovative studies that are aiming to make children’s cancer treatment more tailored.
We spoke to the team looking into the complex relationship between the gut microbiome and radiosensitisation in bladder cancer.
New data suggest that targeted therapy seems to be having an impact on the treatment of lung cancer.
The latest ovarian cancer data from the ICBP reveals that while more people are surviving their cancer, there’s still a long way to go.
Cancer services have been severely disrupted across the UK, from screening to treatment and care.